跳至主要内容
临床试验/ISRCTN58333401
ISRCTN58333401已完成不适用

The clinical effects of leukocyte removal filters, cell savers and their combination on blood transfusion and organ damage during cardiac surgery

niversity Medical Centre Groningen (UMCG) (The Netherlands)0 个研究点目标入组 650 人开始时间: 2005年12月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
650

研究概览

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Adult patients scheduled for cardiac surgery
  • 2. Informed consent
  • The study is not blinded, because intraoperative cell saving cannot be concealed by the size and noise of the apparatus. Blockwise randomisation will be employed to avoid imbalance. Numbered, sealed randomisation envelopes will be used. Randomisation will be registered centrally. The randomisation code will not be revealed to any of the participating investigators.

排除标准

  • 1. Patients with known coagulation disorders except from the use of aspirin or low molecular weight heparin given at least 10 hours before surgery
  • 2. Patients under 18 years
  • 3. Patients presenting for emergency operations

研究者

发起方
niversity Medical Centre Groningen (UMCG) (The Netherlands)

相似试验